0002100397-25-000001.txt : 20251215 0002100397-25-000001.hdr.sgml : 20251215 20251215071827 ACCESSION NUMBER: 0002100397-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20251215 DATE AS OF CHANGE: 20251215 EFFECTIVENESS DATE: 20251215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DE-1112 Fund III, a series of Psychedelic Medicine SPV, LP CENTRAL INDEX KEY: 0002100397 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566748 FILM NUMBER: 251570005 BUSINESS ADDRESS: STREET 1: 2006 196TH ST SW, SUITE 114 CITY: LYNNWOOD STATE: WA ZIP: 98036 BUSINESS PHONE: 2068016359 MAIL ADDRESS: STREET 1: 2006 196TH ST SW, SUITE 114 CITY: LYNNWOOD STATE: WA ZIP: 98036 D 1 primary_doc.xml X0708 D LIVE 0002100397 DE-1112 Fund III, a series of Psychedelic Medicine SPV, LP 2006 196TH ST SW, SUITE 114 LYNNWOOD WA WASHINGTON 98036 2068016359 DELAWARE None None Limited Partnership true 2025 N/A Fund GP, LLC 301 North Market Street Suite 1414 Wilmington DE DELAWARE 19801 Director General partner of the Issuer N/A Belltower Fund Group, Ltd. 119 South Main St, Suite 220 Seattle WA WASHINGTON 98104 Director Agent of the general partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2025-12-12 false true false 1000 216000 216000 0 false 11 0 0 7000 true This amount represents the dollar value of a one-time fee and an annual fee paid to the fund administrator and/or its affiliates to cover administrative expenses for the life of the fund. false DE-1112 Fund III, a series of Psychedelic Medicine SPV, LP /s/ Abraham Wilson Abraham Wilson Authorized Officer of the Agent of Issuer's GP 2025-12-15